Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Vivek Reddy Added: 1 year ago
HRS 25 - First-in-human study demonstrates successful implantation of a novel leadless pacemaker with clinically acceptable intraprocedural electrical performance and safety.We are joined by Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, US) to discuss the findings from a feasibility study investigating the safety and performance of a novel helix-based leadless pacemaker with… View more
Author(s): Added: 6 days ago
HRS Congress 2026 – Dr Shephal Doshi (Pacific Heart Institute, Santa Monica, CA) joins us to discuss findings from the LEAP 2 Chronic Early Feasibility Study, evaluating the safety and performance of the AVEIR CSP Leadless Pacemaker System in patients with standard pacing indications.This prospective, single-arm feasibility study enrolled patients requiring pacemaker implantation to assess… View more
Author(s): Elad Anter Added: 2 weeks ago
HRS Congress 2026 — Prof Elad Anter (Yitzhak Shamir Medical Center, Beer Yakov, IL) joins us to discuss findings from a study investigating reentry at patient-specific atrial regions characterised by steep repolarisation gradients as a mechanism of atrial fibrillation in humans.Interview Questions:What is the current state of debate around reentry as a mechanism of AF, and what has been missing… View more
Author(s): Vivek Reddy Added: 1 year ago
HRS 25 - First-in-human data from the FIH VCAS trial suggests the FieldForce Ablation system can effectively create transmural ablation lesions in patients with scar-related ventricular tachycardia (VT), with an 80% freedom from VT and ventricular fibrillation rate at 6 months.We are joined by Dr Vivek Reddy (Mount Sinai Hospital, New York, US) to discuss the findings from the prospective, first… View more
Job title: Director of Preventive Cardiology
Dr Pradeep Natarajan is Director of Preventive Cardiology at Massachusetts General Hospital, Assistant Professor of Medicine at Harvard Medical School, and Associate Member of the Broad Institute of Harvard and MIT. Dr Natarajan researches the inherited basis of human atherosclerosis using genetic epidemiology, large-scale sequencing studies, genotype-driven human investigation, and genetic… View more
Author(s): Mattias Duytschaever Added: 1 year ago
HRS 2025 - First-in-human three-month results from a contact force-sensing catheter integrated with 3D mapping to treat paroxysmal atrial fibrillation (PAF) show potential for high acute effectiveness and a promising safety profile.Dr Mattias Duytschaever (St Jan Hospital, Bruges, BE) joins us to discuss the three-month findings from the first-in-human Omny-IRE study (NCT05971693; Biosense… View more
Job title: Professor
Added: 3 months ago Source:  AF Symposium
AF Symposium has announced a series of late-breaking scientific sessions scheduled for February 2026, featuring first-in-human data and pivotal trial results across pulsed field ablation (PFA), left atrial appendage (LAA) therapies, and advanced mapping technologies.These sessions will showcase cutting-edge clinical science presented by leading international investigators, with a strong focus on… View more